SkinVive

Microdroplet hyaluronic acid — for cheek smoothness and hydration, not volume.

SkinVive is Allergan’s microdroplet hyaluronic acid injection — the first FDA-approved product of its kind in the U.S. It’s not a volume filler. It targets cheek skin smoothness and hydration through superficial microdroplets of HA placed in the upper dermis.

The result is quieter than filler. You’re not looking for volume change; you’re looking for a smoother, more hydrated appearance to the cheek surface itself — a quality SkinVive addresses that serums and moisturizers can’t.

• MechanismMicrodroplet HA delivered to upper dermis for hydration and smoothness
• Best forCheek smoothness, surface dullness, fine crepeyness
• Not forVolume restoration (see /dermal-filler/ or /sculptra/ for that)
• OnsetVisible smoothness at 2-4 weeks
• Paired withTraditional HA filler (volume), Sculptra (collagen), Hydrafacial

Consult

Your nurse injector assesses whether SkinVive addresses your actual concern. If you’re looking for volume, we’ll recommend a different product.

Treatment

20-30 minutes. Microdroplet injections across the cheek area. Topical numbing typically sufficient.

Onset

2-4 weeks for full effect. The product hydrates and smooths gradually, not instantly.

Maintenance

Re-treatment at ~6 months keeps the surface quality consistent.

Microdroplet hydration injections.